Evaluation of metronomic cyclophosphamide chemotherapy as maintenance treatment for dogs with appendicular osteosarcoma following limb amputation and carboplatin chemotherapy

Journal of the American Veterinary Medical Association
Arata MatsuyamaAnthony J Mutsaers

Abstract

OBJECTIVE To determine the effectiveness of metronomic cyclophosphamide (MC) chemotherapy (primary treatment of interest) with adjuvant meloxicam administration as maintenance treatment for dogs with appendicular osteosarcoma following limb amputation and carboplatin chemotherapy. DESIGN Retrospective case series with nested cohort study. ANIMALS 39 dogs with a histologic diagnosis of appendicular osteosarcoma that underwent limb amputation and completed carboplatin chemotherapy from January 2011 through December 2015. PROCEDURES Dogs were grouped by whether carboplatin chemotherapy had been followed with or without MC chemotherapy (15 mg/m2, PO, q 24 h) and meloxicam (0.1 mg/kg [0.045 mg/lb], PO, q 24 h). The Breslow rank test was used to assess whether MC chemotherapy was associated with overall survival time (OST) and disease progression-free time (PFT) after limb amputation. RESULTS 19 dogs received carboplatin and MC chemotherapy, and 20 dogs received only carboplatin chemotherapy. No differences were identified between these groups regarding age, reproductive status, body weight, serum alkaline phosphatase activity, tumor location, or histologic grade or subtype of osteosarcoma. Median duration of MC chemotherapy for dogs...Continue Reading

References

Mar 1, 1996·Journal of Veterinary Internal Medicine·P J BergmanS J Withrow
May 15, 2002·Veterinary Pathology·J KirpensteijnE Teske
Apr 10, 2003·Journal of Veterinary Internal Medicine·Dennis BaileyMarlene Hauck
Nov 4, 2005·Journal of the American Animal Hospital Association·Ruthanne ChunNicole M Azene
Jan 6, 2009·Journal of the American Animal Hospital Association·Brenda PhillipsDavid M Vail
Jun 10, 2010·Nature Reviews. Clinical Oncology·Eddy PasquierNicolas André
Apr 22, 2011·Investigational New Drugs·Veronica MarchettiGuido Bocci
Dec 14, 2011·Oncotarget·Nicolas AndréArnauld Verschuur
Jan 13, 2012·Veterinary and Comparative Oncology·T N LeachD W Knapp
May 17, 2012·BMC Veterinary Research·Ilse BoermanJolle Kirpensteijn

❮ Previous
Next ❯

Citations

Mar 9, 2021·Frontiers in Veterinary Science·Guillermo ValdiviaLaura Peña

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.